NCIRS evaluation of the impact of the national HPV vaccination program has found that HPV vaccination coverage is high and there has been a substantial reduction in the burden of HPV-related disease since the introduction of the vaccine in Australia. It was also found that adverse events following immunisation with HPV vaccine have been predominantly mild and transient in nature, with the vaccine safety record similar to that of other vaccines on the National Immunisation Program.

This research report presents exploratory analysis of coverage estimates of vaccines/antigens assessed at the 2-year and 5-year age milestone and factors contributing to lower ‘fully vaccinated’ coverage at the 2-year age milestone than at the 5-year age milestone.

NCIRS conducted an exploratory analysis of adult vaccination data for selected vaccines recorded on the Australian Immunisation Register (AIR) for the first 2 years of its establishment (October 2016 – September 2018). This research aims to inform continuous improvement of AIR data to evaluate the National Immunisation Program (NIP) outcomes and to provide improved information and feedback to providers and patients.

This summary report presents key findings from the Annual Immunisation Coverage Report 2018 which focussed on changes in immunisation coverage among all children aged <5 years at key milestone ages of 12, 24 and 60 months between 2017 and 2018.